Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma

C. Tabata, A. Murakami, R. Tabata, H. Okuwa, T. Nakano (Nishimomiya, Amagasaki, Japan)

Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Session: Biology and treatment of malignant pleural effusions
Session type: Oral Presentation
Number: 3079
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Tabata, A. Murakami, R. Tabata, H. Okuwa, T. Nakano (Nishimomiya, Amagasaki, Japan). Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma. Eur Respir J 2012; 40: Suppl. 56, 3079

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012

Management of malignant pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001

Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001


Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019



Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007



Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003

Pleurodesis for malignant pleural effusion
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Pleurodesis for malignant pleural effusion
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015